AT1 3.70% 2.8¢ atomo diagnostics limited

Ann: Atomo and NG Biotech expand COVID-19 partnership, page-41

  1. 432 Posts.
    lightbulb Created with Sketch. 44
    Even if they are making $20 to $25 per kit. 1.5mil kits sold already to NG Biotech that is $30 to $37.5mil in revenue plus more to come in Aus/NZ and Asia.

    may be not a good announcement for traders but looking very positive for medium to long term
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.